Utrecht Holdings

Utrecht Holdings, established in 1998 and located in Utrecht, Netherlands, is a not-for-profit venture capital firm that focuses on investing in various sectors including biotechnology, health technology, animal health, education, digital health, and life sciences. In collaboration with the Economic Board Utrecht, it founded the Utrecht Health Seed Fund in 2020 to specifically target start-ups and seed-stage companies within the life sciences, digital health, medical devices, and animal health sectors. The fund typically invests between €100,000 and €250,000, primarily through convertible loans or equity, often alongside co-investors. Utrecht Holdings aims to support innovative ventures that can contribute to advancements in health and technology.

Timo Koopmans

Investment Manager

2 past transactions

TargED

Series A in 2022
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

TargED

Seed Round in 2020
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.